Goat Anti-Rabbit IgG H&L
Goat Anti-Rabbit IgG H&L
Be the first to review this product! Submit a review
|
(13 Publications)
Suitable for WB, IP, IHC-P, ELISA. Cited in 13 publications.
別名を表示する
Ig gamma 1 chain C region, Ig gamma 3 chain C region, Ig gamma 4 chain C region, Ig gamma chain C region, Ig gamma-2 chain C region, Ig kappa-b4 chain C region, Ig kappa-b5 chain C region, Ig kappa-b9 chain C region, Ig lambda chain C region, Immunoglobin heavy constant gamma 1, Immunoglobulin G, K-BAS
- ELISA
Lab
ELISA - Goat Anti-Rabbit IgG H&L (AB182016)
Cross-reactivity of Goat anti-Rabbit IgG H&L (ab182016) and Goat anti-Rabbit IgG H&L obtained from two different vendors was tested using a sandwich ELISA approach. The wells were coated with the indicated IgG standards (Rabbit, Human, Mouse and Rat) at 1 μg/ml (50 μl/well) and incubated overnight at 4°C, followed by a 5% BSA blocking step for 2h at RT. Secondary antibodies were then added starting at 1 μg/ml and gradually diluted 1/4 (50 μl/well), followed by incubation for 2h. For the detection Donkey anti-Goat IgG H&L (HRP) (ab6885) was used at 1/10,000 dilution (50 μl/well), followed by incubation for 1h at RT. This data is from a representative dilution.
- ELISA
Lab
ELISA - Goat Anti-Rabbit IgG H&L (AB182016)
Cross-reactivity of the polyclonal secondary antibody ab182016 was tested using a sandwich ELISA approach. The wells were coated with the indicated IgG standards at 1 μg/ml (50 μl/well) and incubated overnight at 4°C, followed by a 5% BSA blocking step for 2h at RT. ab182016 was then added starting at 1 μg/ml and gradually diluted 1/4 (50 μl/well), followed by incubation for 2h. For the detection Donkey anti-Goat IgG H&L (HRP) (ab6885) was used at 1/10,000 dilution (50 μl/well), followed by incubation for 1h at RT.
For the batch tested, ab182016 showed a cross-reactivity of 5-7% towards Human IgG and below 2% towards Mouse IgG, Rat IgG and Chicken IgY.
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
文献 (13)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 15:801 PubMed39516467
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:111019 PubMed39429784
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 22:681 PubMed39061056
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 25:770-795 PubMed38182816
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:5656-5666 PubMed38058816
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:8 PubMed36609474
2023
Applications
Unspecified application
Species
Unspecified reactive species
Medicine 101:e31586 PubMed36401373
2022
Applications
Unspecified application
Species
Unspecified reactive species
Diagnostics (Basel, Switzerland) 12: PubMed35741224
2022
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 16:e0258312 PubMed34793477
2021
Applications
Unspecified application
Species
Unspecified reactive species
Andrologia 53:e13954 PubMed33372325
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com